Finch Therapeutics Group, Inc. (FNCHQ) vs NexImmune, Inc. (NEXI)

Finch Therapeutics Group, Inc. and NexImmune, Inc. are both Biotechnology companies. Finch Therapeutics Group, Inc. and NexImmune, Inc. are of similar size ($1.6M and $1.6M). Across the 7 metrics below, NexImmune, Inc. leads on 4 and Finch Therapeutics Group, Inc. on 3.

Valuation

Metric FNCHQ NEXI Biotechnology median
P/E n/m n/m 7.88
P/S 27.07 n/m 11.47
P/B 1.17 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.09 0.74
EV/Sales 47.86 n/m 10.73
Earnings yield (85.22%) 0.00% (28.84%)
Free cash flow yield (100.64%) 0.00% (23.03%)

Profitability

Metric FNCHQ NEXI Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (67.28%) (232.97%) (57.72%)
Return on assets (25.20%) (140.56%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FNCHQ NEXI Biotechnology median
Revenue growth (TTM) (96.00%) — 5.64%
EPS growth (last fiscal year) 35.36% 52.58% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric FNCHQ NEXI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.87 0.66 4.73
Net debt to EBITDA 0.31 0.10 0.96

Dividend

Metric FNCHQ NEXI Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric FNCHQ NEXI Biotechnology median
Market cap 1.57m 1.60m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack